PerkinElmer Inc Valuation – January 2019 $PKI

Company Profile (excerpt from Reuters): PerkinElmer, Inc., incorporated on November 13, 1947, is a provider of products, services and solutions to the diagnostics, research, environmental, industrial and laboratory services markets. The Company operates through two segments: Discovery & Analytical Solutions and Diagnostics.

PKI Chart

PKI data by YCharts

 

Downloadable PDF version of this valuation:

ModernGraham Valuation of PKI – January 2019

Stage 1: Is this company suitable for the Defensive Investor or the Enterprising Investor?

What kind of Intelligent Investor are you?

Defensive Investor; must pass 6 out of the following 7 tests.
1. Adequate Size of the Enterprise Market Cap > $2Bil $9,611,049,769 Pass
2. Sufficiently Strong Financial Condition Current Ratio > 2 1.70 Fail
3. Earnings Stability Positive EPS for 10 years prior Pass
4. Dividend Record Dividend Payments for 10 years prior Pass
5. Earnings Growth Increase of 33% in EPS in past 10 years using 3 year averages at beginning and end 79.56% Pass
6. Moderate PEmg Ratio PEmg < 20 36.87 Fail
7. Moderate Price to Assets PB Ratio < 2.5 OR PB*PEmg < 50 3.75 Fail
Enterprising Investor; must pass 4 out of the following 5 tests, or be suitable for the Defensive Investor.
1. Sufficiently Strong Financial Condition Current Ratio > 1.5 1.70 Pass
2. Sufficiently Strong Financial Condition Debt to NCA < 1.1 3.93 Fail
3. Earnings Stability Positive EPS for 5 years prior Pass
4. Dividend Record Currently Pays Dividend Pass
5. Earnings Growth EPSmg greater than 5 years ago Pass

 

Stage 2: Determination of Intrinsic Value

EPSmg $2.34
MG Growth Estimate 14.11%
MG Value $86.06
Opinion Fairly Valued
MG Grade C+
MG Value based on 3% Growth $33.98
MG Value based on 0% Growth $19.92
Market Implied Growth Rate 14.19%
Current Price $86.40
% of Intrinsic Value 100.39%

PerkinElmer, Inc. is suitable for the Enterprising Investor but not the more conservative Defensive Investor. The Defensive Investor is concerned with the low current ratio, high PEmg and PB ratios. The Enterprising Investor is only concerned with the level of debt relative to the net current assets. As a result, all Enterprising Investors following the ModernGraham approach should feel comfortable proceeding with the analysis.

As for a valuation, the company appears to be Fairly Valued after growing its EPSmg (normalized earnings) from $1.21 in 2014 to an estimated $2.34 for 2018. This level of demonstrated earnings growth supports the market’s implied estimate of 14.19% annual earnings growth over the next 7-10 years. As a result, the ModernGraham valuation model, based on the Benjamin Graham value investing formula, returns an estimate of intrinsic value within a margin of safety relative to the price.

At the time of valuation, further research into PerkinElmer, Inc. revealed the company was trading above its Graham Number of $36.57. The company pays a dividend of $0.28 per share, for a yield of 0.3% Its PEmg (price over earnings per share – ModernGraham) was 36.87, which was below the industry average of 52.7, which by some methods of valuation makes it one of the most undervalued stocks in its industry. Finally, the company was trading above its Net Current Asset Value (NCAV) of $-19.01.

PerkinElmer, Inc. receives an average overall rating in the ModernGraham grading system, scoring a C+.

Stage 3: Information for Further Research

Net Current Asset Value (NCAV) -$19.01
Graham Number $36.57
PEmg 36.87
Current Ratio 1.70
PB Ratio 3.75
Current Dividend $0.28
Dividend Yield 0.32%
Number of Consecutive Years of Dividend Growth 0

Useful Links:

ModernGraham tagged articles Morningstar
Google Finance MSN Money
Yahoo Finance Seeking Alpha
GuruFocus SEC Filings

Most Recent Balance Sheet Figures

Balance Sheet Information 9/1/2018
Total Current Assets $1,165,495,000
Total Current Liabilities $686,752,000
Long-Term Debt $1,882,502,000
Total Assets $5,862,355,000
Intangible Assets $4,144,464,000
Total Liabilities $3,289,886,000
Shares Outstanding (Diluted Average) 111,747,000

Earnings Per Share History

EPS History
Next Fiscal Year Estimate $2.62
Dec2017 $2.64
Dec2016 $2.12
Dec2015 $1.87
Dec2014 $1.39
Dec2013 $1.47
Dec2012 $0.61
Dec2011 $0.07
Dec2010 $3.31
Dec2009 $0.73
Dec2008 $1.07
Dec2007 $1.09
Dec2006 $0.95
Dec2005 $2.04
Dec2004 $0.74
Dec2003 $0.41
Dec2002 -$1.21
Dec2001 $0.32
Dec2000 $0.89
Dec1999 $0.29
Dec1998 $1.11

Earnings Per Share – ModernGraham History

EPSmg History
Next Fiscal Year Estimate $2.34
Dec2017 $2.10
Dec2016 $1.72
Dec2015 $1.37
Dec2014 $1.21
Dec2013 $1.16
Dec2012 $1.05
Dec2011 $1.27
Dec2010 $1.72
Dec2009 $1.01
Dec2008 $1.16
Dec2007 $1.15
Dec2006 $0.98
Dec2005 $0.82
Dec2004 $0.22
Dec2003 $0.02
Dec2002 -$0.03

Recommended Reading:

Other ModernGraham posts about the company

PerkinElmer Inc Valuation – March 2018 $PKI
9 Best Stocks For Value Investors This Week – 7/8/16
PerkinElmer Inc Valuation – July 2016 $PKI
PerkinElmer Inc Valuation – January 2016 Update $PKI
PerkinElmer Inc. Analysis – October 2015 Update $PKI

Other ModernGraham posts about related companies

Zimmer Biomet Holdings Inc Valuation – January 2019 $ZBH
Henry Schein Inc Valuation – January 2019 $HSIC
Medtronic PLC Valuation – January 2019 $MDT
UnitedHealth Group Inc Valuation – November 2018 $UNH
Luminex Corp Valuation – October 2018 $LMNX
LHC Group Inc Valuation – September 2018 $LHCG
Chartwell Retirement Residences Valuation – August 2018 $TSE:CSH.UN
STERIS PLC Valuation – August 2018 $STE
CryoLife Inc Valuation – August 2018 $CRY
Charles River Laboratories International Inc Valuation – August 2018 $CRL

Disclaimer:

The author did not hold a position in any company mentioned in this article at the time of publication and had no intention of changing that position within the next 72 hours.  See my current holdings here.  This article is not investment advice; any reader should speak to a registered investment adviser prior to making any investment decisions.  ModernGraham is not affiliated with the company in any manner.  Please be sure to review our detailed disclaimer.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.